Cinaciguat
Product Specifications
UNSPSC Description
Cinaciguat is an activator of guanylate cyclase (sGC), and used for acute decompensated heart failure.
Target Antigen
Guanylate Cyclase
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Cinaciguat.html
Solubility
DMSO : ≥ 50 mg/mL
Smiles
OC(C(C=C1)=CC=C1CN(CCCCC(O)=O)CCC(C=CC=C2)=C2OCC(C=C3)=CC=C3CCC4=CC=CC=C4)=O
Molecular Weight
565.70
References & Citations
[1]Mátyás C, et al. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cardiovasc Diabetol. 2015 Oct 31;14:145.|[2]Reinke Y, et al. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats. Format: AbstractSend to Eur J Pharmaco|[3]Cosyns SM, et al. Influence of cinaciguat on gastrointestinal motility in apo-sGC mice. Neurogastroenterol Motil. 2014 Nov;26(11):1573-85.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14181/Cinaciguat-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14181/Cinaciguat-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
329773-35-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1582210-03 5x 100 Tests
Anti-Human CCL24/Eotaxin-2/MPIF-2 Antibody (SAA0461), APC
Ask
View Details